April, 2018

Both Traditional and Newly Expanded Medicaid Population Will Drive Specialty and Biosimilar Drug Spend

Learn more about Medicaid pharmacy spend in our recently released research Medicaid Reimbursement and Design.

April, 2018

Who Holds the Most Influence over Site-of-Care Choices?

Most Say, "The Other Guy!" Click to learn more.

April, 2018

Across Stakeholders, Spiriva, Flovent, and Ventolin Continue to Lead Brands in Access

Read more about how stakeholders are increasingly selecting one or two market-leading respiratory brands as first line options.

April, 2018

Payers and Providers Facilitate Access to Multiple MS Drugs, Providing Prescribing Options as Needed

Read more to get an inside view into our recently released Brand Access Marketplace Dynamics: Multiple Sclerosis Market Access Stakeholder Drug Management Landscape.

April, 2018

Payer Efforts Have Incorporated Stakeholder Support to Improve Compliance with Quality Measures

Learn more about payer and health system strategies to improve compliance with quality measures.

March, 2018

Payers Shift Additional Cost and Decision Making Authority to Consumers

Read more about the current trends in pharmacy and medical benefit designs across Medicare, Medicaid, and commercial channels.

March, 2018

Government Payers: Policy Update

Click to read a research finding from our recent Market Alert.

March, 2018

Combined Albertsons–Rite Aid Projects $83 Billion in 2018 Revenue

Click to read a research finding from our recent Market Alert.

March, 2018

Stakeholders Prioritize Six Key Elements When Developing Strategies to Address Population Health Issues

Learn more about this Key Finding from our Value, Quality, and Reimbursement research.

March, 2018

TNF Inhibitors Continue to Lead In Brand Access Across Stakeholders; Orencia, Otezla, Costenyx Fall Next in Line

Read more to get an inside view into our recently released Brand Access Marketplace Dynamics: Autoimmune Market Access Stakeholder Drug Management Landscape research.

Pages

Subscribe to RSS - mwalburger's blog

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.